Table 1. Summary of patient details for c-Cbl and TEAD1 staining.

	Patient summary
	c-Cbl	TEAD1
Total cancers	101	96
Total benign	90	95
Age range (years)	43–84	43–84
Median age (years)	64	66
Follow-up time (years)	0.4–16.6	1.25–16.6
Median follow-up (years)	6.75	6.85
AJCC stage
I	2	2
II	36	34
III	24	24
IV LA T4 or N1	16	16
IV metastatic	23	20
Gleason grade
Well (2–4)	17	18
Moderate (5–7)	54	50
Poor (8–10)	29	26
Missing	1	2
Staining summary
	Total positive	Metastasis positive	Gleason<7	Gleason⩾7
CBL 1	32	8 (25%)	22 (71%)	9 (29%)
CBL 2	44	9 (21%)	27 (61%)	17 (39%)
CBL 3	25	6 (24%)	11 (44%)	14 (56%)
TEAD1 0	7	1 (14%)	6 (86%)	1 (14%)
TEAD1 1	30	6 (24%)	22 (75%)	7 (25%)
TEAD1 2	49	10 (20%)	21 (44%)	27 (56%)
TEAD1 3	10	3 (30%)	2 (20%)	8 (80%)
TEAD1 focal	53	14 (26.5%)	40 (75.5%)	12 (22.6%)
TEAD1 diffuse	36	18 (50%)	11 (30.6%)	24 (66.7%)